Thereafter, increasing concentrations of retatrutide were cumulatively applied (Fig
Read clinical review Questions GIP/GLP-1 Dual Agonists: How to Select the Right Agent Within the Class A prescriber-level guide to GIP/GLP-1 dual agonists covering mechanism, agent selection, dosing, trial data, and clinical decision-making for weight loss, T2D, sleep apnea, and HFpEF
These mediators collectively drive the process of secondary neurological injury by activating endothelial cells, recruiting immune cells, and disrupting the BBB
What is measured in these rats and mice (and occasionally in small groups of human volunteers) is often not a hard endpoint like muscle strength or weight loss, but surrogate biomarkers: molecules in the blood that have an indirect link to a hard endpoint